April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A-Cationic Emulsion to Pigmented Rabbits
Author Affiliations & Notes
  • Frederic Lallemand
    R & D, Novagali Pharma, Evry, France
  • Grégory Lambert
    R & D, Septodont, St Maur des fosses, France
  • Laura Rabinovich
    R & D, Teva Pharmaceutics, Netanya, Israel
  • Philippe Daull
    R & D, Novagali Pharma, Evry, France
  • Jean-Sébastien Garrigue
    R & D, Novagali Pharma, Evry, France
  • Footnotes
    Commercial Relationships  Frederic Lallemand, Novagali Pharma (E); Grégory Lambert, None; Laura Rabinovich, None; Philippe Daull, Novagali Pharma (E); Jean-Sébastien Garrigue, Novagali Pharma (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3785. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Frederic Lallemand, Grégory Lambert, Laura Rabinovich, Philippe Daull, Jean-Sébastien Garrigue; Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A-Cationic Emulsion to Pigmented Rabbits. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3785.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The goal of the present studies was to compare the ocular and systemic cyclosporine A (CsA) distribution following single and multiple dosing in pigmented rabbits of the CsA-cationic emulsion and Restasis®.

Methods: : Cationic oil-in-water emulsions containing various concentrations of CsA, ranging from 0.025 to 0.1% were applied in the conjunctival sac of pigmented rabbits, as a single instillation for single dose PK, or in a repeated manner for multiple doses PKs. For the single dose PK, 6 animals per time point were instilled once with 50 µl of the test material. At each time point (0.33, 0.67, 1, 2, 4, 8, 12, 24, 48, and 72h) the cornea, conjunctiva and whole blood were harvested for CsA concentration determination. For the multiple dose PKs, the rabbits were instilled with 50µl, either qid for 7 days, or bid for 10 days, before collecting either, eyes and general organs, or the cornea, conjunctiva and whole blood, respectively. Restasis® was used as a reference in the 3 studies.

Results: : Single dose PK data demonstrated that the cationic emulsion was more effective than Restasis® at delivering CsA to the cornea (Cmax: 1372 vs 748 ng/g; AUC: 26477 vs. 14210 ng/g.h, respectively). Conjunctival concentrations were not statistically different; Cmax: 696 vs. 849 ng/g, AUC: 2781 vs. 2375 ng/g.h, for CsA-cationic emulsion and Restasis®, respectively. The multiple dose PKs confirmed that there was no systemic absorption, with values below the LOD (0.1 ng/ml) for the CsA-cationic emulsion. The use of 3H-CsA demonstrated that the systemic distribution following repeated instillations was indeed low for both CsA-cationic emulsion and Restasis®, and comparable.

Conclusions: : The data demonstrated that the CsA-cationic emulsion was more effective than Restasis® at delivering therapeutic doses of CsA to target tissues, thus confirming the advantage of cationic emulsions over anionic emulsions as vehicle for ocular delivery.

Keywords: cyclosporine • inflammation • cornea: tears/tear film/dry eye 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×